搜尋
Tevogen Bio Holdings Inc
TVGN添加自選
6.690USD
-0.030-0.45%
收盤 07-31 16:00（美東）報價延遲15分鐘
537.98K總市值
虧損本益比TTM
關於 Tevogen Bio Holdings Inc 公司
Tevogen Bio Holdings Inc. is a clinical-stage specialty immunotherapy company. The Company is harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs), to develop off-the-shelf, genetically unmodified precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders, aiming to address the unmet needs of patient populations. Its first product candidate, TVGN 489, has developed to fill a critical gap in COVID-19 therapeutics for the immunocompromised and the high-risk elderly, with potential applications in both treatment and prevention of chronic lingering symptoms of the disease. Its TVGN 601 is being developed for multiple sclerosis (MS), and its TVGN 930 is being developed for EBV-associated lymphomas.
Tevogen Bio Holdings Inc簡介
公司代碼TVGN
公司名稱Tevogen Bio Holdings Inc
上市日期Nov 04, 2021
CEOSaadi (Ryan)
員工數量18
證券類型Ordinary Share
年結日Nov 04
公司地址15 Independence Boulevard, Suite #210
城市WARREN
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編07059
電話16468078832
網址https://tevogen.com/
公司代碼TVGN
上市日期Nov 04, 2021
CEOSaadi (Ryan)
Tevogen Bio Holdings Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Kirti Desai
Mr. Kirti Desai
Chief Financial Officer
Chief Financial Officer
242.98K
+16.46%
Dr. Neal Flomenberg, M.D.
Dr. Neal Flomenberg, M.D.
Chief Scientific Officer and Global R&D Lead
Chief Scientific Officer and Global R&D Lead
74.52K
+3.25%
Mr. Jeffrey Feike
Mr. Jeffrey Feike
Independent Director
Independent Director
54.03K
+74.03%
Dr. Keow Lin (Lindee) Goh
Dr. Keow Lin (Lindee) Goh
Independent Director
Independent Director
46.28K
+86.43%
Ms. Susan M. Podlogar
Ms. Susan M. Podlogar
Independent Director
Independent Director
46.28K
+86.43%
Mr. Sadiq Khan
Mr. Sadiq Khan
Chief Commercial Officer
Chief Commercial Officer
4.00K
--
Dr. Ryan Saadi, M.D.
Dr. Ryan Saadi, M.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Dr. Curtis Patton
Dr. Curtis Patton
Independent Director
Independent Director
--
--
Mr. Victor Sordillo
Mr. Victor Sordillo
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Kirti Desai
Mr. Kirti Desai
Chief Financial Officer
Chief Financial Officer
242.98K
+16.46%
Dr. Neal Flomenberg, M.D.
Dr. Neal Flomenberg, M.D.
Chief Scientific Officer and Global R&D Lead
Chief Scientific Officer and Global R&D Lead
74.52K
+3.25%
Mr. Jeffrey Feike
Mr. Jeffrey Feike
Independent Director
Independent Director
54.03K
+74.03%
Dr. Keow Lin (Lindee) Goh
Dr. Keow Lin (Lindee) Goh
Independent Director
Independent Director
46.28K
+86.43%
Ms. Susan M. Podlogar
Ms. Susan M. Podlogar
Independent Director
Independent Director
46.28K
+86.43%
Mr. Sadiq Khan
Mr. Sadiq Khan
Chief Commercial Officer
Chief Commercial Officer
4.00K
--
常見問題
Tevogen Bio Holdings Inc的前五大股東是誰？
Tevogen Bio Holdings Inc的前五大股東如下：Mr. Kirti Desai
有多少機構持有Tevogen Bio Holdings Inc(TVGN)的股份？
截至2026Q1，共有115家機構持有Tevogen Bio Holdings Inc的股份，合計持有的股份價值約為168.15K，占公司總股份的4.02% 。與2025Q4相比，機構持股有所增加，增幅為-44192.00。